Poloxamer 182 (L62)
Based on 1 Customer Validation
Poloxamer 182 (L62) can be used as an excipient, such as Emulsifier, solubilizer, lubricant, etc. Pharmaceutical excipients, or pharmaceutical auxiliaries, refer to other chemical substances used in the pharmaceutical process other than pharmaceutical ingredients. Pharmaceutical excipients generally refer to inactive ingredients in pharmaceutical preparations, which can improve the stability, solubility and processability of pharmaceutical preparations. Pharmaceutical excipients also affect the absorption, distribution, metabolism, and elimination (ADME) processes of co-administered drugs.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 9003-11-6
- Masse moléculaire:2500(Average)
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
- Pureté et documentation
- Références
-
Help & FAQs
-
HY-D1005A
Poloxamer 188
-
HY-D1005
Poloxamer 407 (F127)
-
HY-D1005H
Poloxamer 188 (F68)
-
HY-D1005A6
Poloxamer 124 (L44)
-
HY-D1005A22
Poloxamer 338 (F108)
-
HY-D1005A25
Poloxamer 403 (P123)
-
HY-D1005A23
Poloxamer 401 (L121)
-
HY-D1005A10
Poloxamer 184 (L64)
-
HY-D1005B
Poloxamer 237 (F87)
-
HY-D1005A2
Poloxamer 105 (L35)
-
HY-D1005A8
Poloxamer 181 (L61)
-
HY-D1005K
Poloxamer L64
Activité biologique
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 9003-11-6
-
Appearance Liquid (Density: 1.018 g/cm3)
-
Masse moléculaire 2500(Average)
-
Color Colorless to light yellow
-
SMILES
CC.[H(OCH2CH2)x(OCH2CH)y(OCH2CH2)zOH].[CH3]
-
Synonyms
PEG-PPG-PEG, 2500(Average Mn)
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
-
Fiche technique (265 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Instruction de manipulation (2659 KB)
Références
[1]. Elder DP, et al. Pharmaceutical excipients - quality, regulatory and biopharmaceutical considerations. Eur J Pharm Sci. 2016 May 25;87:88-99. [Content Brief]
[2]. Carvalho GC, et al. Highlights in poloxamer-based drug delivery systems as strategy at local application for vaginal infections. Int J Pharm. 2021 Jun 1;602:120635. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Poloxamer 182 (L62) Related Classifications
HY-D1005F Related Classifications
Powered by Bioz